MYCOBACTERIUM ABSCESSUS INFECTION
Clinical trials for MYCOBACTERIUM ABSCESSUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new MYCOBACTERIUM ABSCESSUS INFECTION trials appear
Sign up with your email to follow new studies for MYCOBACTERIUM ABSCESSUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo takes on rare, Drug-Resistant lung bug
Disease control Not yet recruitingThis trial tests a new combination of antibiotics (called Arm D) against standard treatments for a rare lung infection caused by Mycobacterium abscessus. About 300 people with or without cystic fibrosis will take part. The goal is to see if the new combo clears the infection bett…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Desperate times: phage cocktail takes on Drug-Resistant lung bug
Disease control Not yet recruitingThis early study tests a special cocktail of viruses (phages) designed to attack a drug-resistant bacterium causing chronic lung infection. Only one person will receive the treatment alongside their usual antibiotics. The goal is to see if it's safe and can reduce the amount of b…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE1 • Sponsor: Alberta Health services • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC